Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Anu Lala"'
Autor:
Moritz Blum, Li Zeng, Karen Hiensch, Anup Bharani, Emily Chai, Anuradha (Anu) Lala, Nathan Goldstein, Laura Gelfman
Publikováno v:
Journal of the American College of Cardiology. 81:707
Autor:
Estefania Oliveros, Soheila Talebi, Aditya Parikh, Yevgeniy Brailovsky, Johanna Contreras, Robert Leber, Anu Lala, Ashish Correa
Publikováno v:
Circulation. 142
Introduction: High-output heart failure (HF) develops in the setting of excessive cardiac output. Case Presentation: 65-year-old male with HF (EF 40%), severe right ventricular dysfunction, and emphysema presented with dyspnea and anasarca. On admiss
Autor:
Aarti Rao, Anuradha (Anu) Lala
Publikováno v:
Journal of the American College of Cardiology. 79:444
Autor:
Anu Lala, Johanna Contreras, Vivian M. Abascal, Donna M. Mancini, Farah Atallah-Lajam, Ronald Tamler, Carlos G. Santos-Gallego, Icilma V. Fergus, Alvaro Garcia-Ropero, Sean Pinney, Javier Sanz, Juan J. Badimon, Valentin Fuster, Pedro R. Moreno
Publikováno v:
Cardiovascular drugs and therapy. 33(1)
The SGLT2 inhibitor empagliflozin reduced cardiovascular mortality by 38% and heart failure (HF) hospitalizations by 35% in diabetic patients. We have recently demonstrated the efficacy of empagliflozin in ameliorating HF and improving cardiac functi
Autor:
Josef Stehlik, Quinn Wells, Adrian F. Hernandez, Alexandros Briasoulis, Juan Vilaro, Anuradha (Anu) Lala, Peter M. Eckman, Kurt G. Barringhaus, Ravi Dhingra, Xian Shen, Haolin Xu, Jo E. Rodgers, Emily C. O'Brien, Tamas Alexy, Marc A. Simon, Shannon M. Dunlay, Robert J. Mentz, Martha Abshire, Johana Espinoza, Brian Lowes, Rosalia Blanco, Carol I. Duffy, Laine Thomas, Bhanu Gupta
Publikováno v:
Journal of the American College of Cardiology. 75:810
PARADIGM-HF showed that sacubitril/valsartan (sac/val) improved quality of life (QOL) vs enalapril in heart failure with reduced ejection fraction (HFrEF), yet limited data are available regarding QOL changes after sac/val initiation in routine pract
Autor:
Judy Hung, Michael A. Acker, Marissa A. Miller, Katherine A. Kirkwood, Alan J. Moskowitz, Gennaro Giustino, Anuradha (Anu) Lala-Trindade, Peter K. Smith, A. M Gillinov, Jessica Overbey, Annetine C. Gelijns, Mary-Lu Mayer, Doris A. Taylor, Emilia Bagiella, Gorav Ailawadi, Patrick T. O'Gara, François Dagenais
Publikováno v:
Journal of the American College of Cardiology. 73:1951
Autor:
Alan J. Moskowitz, Sean Pinney, Francis D. Pagani, Anuradha (Anu) Lala-Trindade, Marissa A. Miller, John Rowland, Bart S. Ferket, Donna Mancini, Emilia Bagiella, Annetine C. Gelijns
Publikováno v:
Journal of the American College of Cardiology. 73:1018
Publikováno v:
Journal of Cardiac Failure. 24:S75
Background Heart failure (HF) remains one of the leading causes of 30-day hospital readmissions. In this study, we examined the feasibility of incorporating RecoverLINK, a digital health technology, into the standard of care for recently discharged H
Publikováno v:
Journal of Cardiac Failure. 24:S52
Introduction One strategy to reduce 30-day hospital readmission is to provide outpatient follow up to all heart failure patients in a dedicated clinic within 7 days of discharge. We hypothesized that the use of remote dielectric sensing (ReDS) techno
Autor:
Mary Ann McLaughlin, Anu Lala
Publikováno v:
Current Hypertension Reports. 10:286-292
The Heart Outcomes Prevention (HOPE) trial was the first to demonstrate the benefits of the angiotensin-converting enzyme (ACE) inhibitor ramipril for high-risk cardiovascular patients. Whether the cardioprotective effects seen in HOPE and other tria